In vitro effects of continuous pressure with zidovudine (ZDV) and lamivudine on a ZDV-resistant HIV-1 isolate

被引：0
|
作者：
Rusconi, S
DePasquale, MP
Milazzo, L
Bulgheroni, E
Citterio, P
Kurtagic, S
dArminioMonforte, A
Galli, M
机构：
来源：
AIDS | 1997年 / 11卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1406 / 1410
页数：5
相关论文
共 50 条
  • [1] Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure
    Rusconi, S
    De Pasquale, MP
    Milazzo, L
    Kurtagic, S
    Bulgheroni, E
    Citterio, P
    Galazzi, M
    Catamancio, SL
    Galli, M
    [J]. ANTIVIRAL THERAPY, 1998, 3 (04) : 203 - 207
  • [2] PARVOVIRUS B19 INFECTION IN HIV-1 INFECTED INDIVIDUALS FAILING OR INTOLERANT TO ZIDOVUDINE (ZDV) THERAPY
    NAIDES, SJ
    HOWARD, EJ
    SWACK, NS
    STAPLETON, JT
    [J]. CLINICAL RESEARCH, 1991, 39 (03): : A727 - A727
  • [3] IN-VITRO AND IN-VIVO CORRELATES OF ZDV/DDI/NEVIRAPINE THERAPY OF HIV-1 INFECTION
    SULLIVAN, JL
    BREWSTER, F
    SOMASUNDARAN, M
    GREENOUGH, T
    PAULETTI, D
    SHIH, CK
    GRIFFIN, J
    MYERS, M
    LUZURIAGA, K
    [J]. PEDIATRIC RESEARCH, 1994, 35 (04) : A197 - A197
  • [4] Selection in vitro of an HIV-1 variant resistant to both lamivudine (3TC) and zidovudine
    Goulden, MG
    Cammack, N
    Hopewell, PL
    Penn, CR
    Cameron, JM
    [J]. AIDS, 1996, 10 (01) : 101 - 102
  • [5] HIV type 1 zidovudine (ZDV) resistance in blood and uterine cervical secretions of pregnant women
    Frenkel, Lisa M.
    McKernan, Jennifer
    Dinh, Phil V.
    Goldman, Deborah
    Hitti, Jane
    Watts, D. Heather
    Cooper, Ellen R.
    Dragavon, Joan
    Coombs, Robert W.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (09) : 870 - 873
  • [6] Resistance emergence to zidovudine (ZDV) and lamivudine (3TC(TM)) in HIV-1-infected patients in an ongoing open label trial
    Rusconi, S
    dePasquale, MP
    Milazzo, L
    Moscatelli, G
    Kurtagic, S
    dArminioMonforte, A
    Galli, M
    [J]. AIDS, 1996, 10 : P6 - P6
  • [7] Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication
    Bisset, LR
    Lutz, H
    Böni, J
    Hofmann-Lehmann, R
    Lüthy, R
    Schüpbach, J
    [J]. ANTIVIRAL RESEARCH, 2002, 53 (01) : 35 - 45
  • [8] Intrapartum zidovudine (ZDV) infusion alone failed to reduce maternal HIV-1 viremia and vertical transmission in HIV-1 infected pregnant women with no prior antenatal care
    Virutamasen, P
    Limpongsanurak, S
    Ruxrungtham, K
    Thisayakom, U
    Thaithamyanond, P
    Reinprayoon, D
    Hanvanich, M
    Likitnukul, S
    Sathapompongse, K
    Chuansanti, S
    Nimkam, S
    Phanuphak, P
    [J]. AIDS, 1996, 10 : OP52 - OP52
  • [9] PHARMACOKINETICS (PK) OF ORAL LAMIVUDINE ADMINISTERED ALONE WITH ORAL ZIDOVUDINE (ZDV) IN ASYMPTOMATIC PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
    HORTON, CM
    YUEN, G
    MIKOLICH, DM
    FISHER, A
    RANA, K
    MYDLOW, P
    DUDLEY, MN
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 198 - 198
  • [10] Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and Zidovudine (ZDV)
    Raise, E
    Guerra, L
    Viza, D
    Pizza, G
    DeVinci, C
    Schiattone, ML
    Rocaccio, L
    Cicognani, M
    Gritti, F
    [J]. BIOTHERAPY, 1996, 9 (1-3) : 49 - 54
12345